Job Watch

Oxford Nanopore Technologies: Bioinformatics Team Lead - Molecular Diagnostics

New Scientist - Bioinformatics - Tue, 2022-04-05 06:57
Negotiable: Oxford Nanopore Technologies: Looking to develop your career with a sophisticated technology leader developing the next generation of clinical diagnostic tests? Oxford, England
Categories: Job Watch

National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate Research Training Program (T34)

Funding Opportunity PAR-22-125 from the NIH Guide for Grants and Contracts. The goal of the Bridges to the Baccalaureate Research Training Program is to provide structured activities to prepare a diverse cohort of research-oriented students to transfer from associate degree-granting to baccalaureate degree-granting institutions and complete a baccalaureate degree in biomedical research fields. This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-informed approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring, and career development elements. This program requires strong partnerships between at least two post-secondary educational institutions offering science, technology, engineering, or mathematics (STEM) degrees. At least one partner must be an institution that offers the associate degree as the highest STEM degree and the other partner(s) must offer baccalaureate degrees in biomedically relevant STEM fields. Upon completion of the Bridges to the Baccalaureate Research Training program, trainees are expected to be well positioned to pursue a research-oriented biomedical higher degree program or enter careers in the biomedical research workforce.This FOA does not allow appointed trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

Laboratories to Optimize Digital Health (R01 Clinical Trial Required)

Funding Opportunity PAR-22-154 from the NIH Guide for Grants and Contracts. NIMH seeks applications for innovative research projects to test strategies to increase the reach, efficiency, effectiveness, and quality of digital mental health interventions. This FOA is intended to support the development of digital health test beds that leverage well-established digital mental health platforms,to rapidly refine and optimize existing evidence-based digital health interventions and conduct clinical trials testing digital mental health interventions that are statistically powered to provide a definitive answer regarding the intervention's effectiveness.

Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)

Funding Opportunity RFA-CA-22-020 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs.Applicants should have a working assay or device prototype (not necessarily already capable of cancer applications). The U01 project includes studies to both adapt this technology as well as demonstrate technical functionality and clinical performance for use of the device or assay in specific LMIC settings by meeting objective performance milestones followed by improvements and validations of the technologies in the LMIC settings. Projects proposed in response to this FOA will require multidisciplinary efforts to succeed; therefore, all applicant teams must include expertise in engineering/assay/treatment development, oncology, global healthcare delivery, and business development. Investigators responding to this FOA must consider affordability and cost-effectiveness as well as usability at the point-of-need as part of their design criteria.This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program.

Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)

Funding Opportunity RFA-OD-22-010 from the NIH Guide for Grants and Contracts. The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R61/R33) grant applications to support development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome. The proposed research aims should be milestone-driven. The total project period for an application submitted in response to this FOA may not exceed five years. This FOA provides support for up to two years (R61 phase) for preliminary/developmental/planning studies, followed by possible transition to clinical trial support (R33) of up to three years, although the total duration of the award may not exceed five years. This FOA requires measurable R61 milestones.

Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-OD-22-009 from the NIH Guide for Grants and Contracts. The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. This Funding Opportunity Announcement (FOA) is soliciting Transformative Research Award applications to support individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research that has the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies related to Down syndrome. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the nations research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. Applications are welcome in all topics relevant to Down syndrome-related research or its co-occurring conditions. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in research related to Down syndrome.

INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)

Funding Opportunity RFA-OD-22-007 from the NIH Guide for Grants and Contracts. The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in Down syndrome. This initiative seeks applications that are intended to facilitate Down syndrome research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials for Down syndrome and its co-occurring conditions, and to increase their likelihood of success through development and testing of biomarkers and clinical outcome assessment measures, development and testing of novel trial methods and recruitment strategies, or by defining the presentation and course of the co-occurring conditions in individuals with Down syndrome to enable the design of future clinical trials.

Sr. Scientist, Protein/Antibody Engineering - Arrowhead Pharmaceuticals - Madison, WI

Indeed.com - Bioinformatics - Mon, 2022-04-04 20:09
Skilled in the use of bioinformatics tools for antibody repertoire sequence and structure analyses. Present research findings to project teams and governance…
From Indeed - Tue, 05 Apr 2022 00:09:52 GMT - View all Madison, WI jobs
Categories: Job Watch

Wellcome Sanger Institute: Senior Bioinformatician

New Scientist - Bioinformatics - Mon, 2022-04-04 10:45
£38,433- £46,000 per annum: Wellcome Sanger Institute: We have a new and exciting opportunity for a Senior Bioinformatician to join the Global Pneumococcal Sequencing (GPS) project and the JUNO project.... Cambridgeshire (GB)
Categories: Job Watch

Reducing Racial and Ethnic Healthcare Disparities in Chronic Conditions by Dissemination and Implementation of Patient Centered Outcomes Research (PCOR) Evidence (R18)

Funding Opportunity RFA-HS-22-001 from the NIH Guide for Grants and Contracts. The Agency for Healthcare Research and Quality (AHRQ) seeks applications to disseminate and implement patient-centered outcomes research (PCOR) findings into innovative, evidence-based interventions to reduce healthcare disparities in chronic health conditions. Applications to this Notice of Funding Opportunity (NOFO) are required to disseminate and implement PCOR findings across healthcare settings to address disparities in health outcomes and quality for racial and ethnic minority populations and AHRQ priority populations. Interventions must be focused on improving dissemination and implementation of evidence-based strategies, with the specific goal of reducing health and healthcare disparities. Though not limited to the following, areas where evidence-based interventions have demonstrated disparities reduction include: 1. Improving Control and Management of Chronic Conditions including Cardiovascular Disease (CVD); 2. Promoting Improved Cancer and Chronic Condition Screening; and 3. Improving Prenatal Care, Maternal Health, and Infant Mortality

CK Group: Senior Research Scientist - Translational Science

New Scientist - Bioinformatics - Sun, 2022-04-03 20:00
£0 - £48000 per annum: CK Group: CK Group are recruiting for a Senior Research Scientist on behalf of a fast paced, trail blazing biotechnology company focussed on the development of T... Stevenage
Categories: Job Watch

Research Scientist I - Pediatric Clinical Effectiveness Research - Medical College of Wisconsin - Milwaukee, WI

Indeed.com - Bioinformatics - Fri, 2022-04-01 17:15
Experience with gene expression analyses, computational biology, genomics and bioinformatics desired. Knowledge of current technological developments/trends…
From Medical College of Wisconsin - Fri, 01 Apr 2022 21:15:11 GMT - View all Milwaukee, WI jobs
Categories: Job Watch

Pages

Subscribe to Anil Jegga aggregator - Job Watch